Login / Signup

Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?

Lucas MorinAdam ToddStephen BarclayJonas W WastessonJohan FastbomKristina Johnell
Published in: Cancer (2019)
Preventive drugs commonly are prescribed during the last year of life among older adults with cancer, and often are continued until the final weeks before death. Adequate deprescribing strategies are warranted to reduce the burden of drugs with limited clinical benefit near the end of life.
Keyphrases
  • papillary thyroid
  • squamous cell
  • lymph node metastasis
  • squamous cell carcinoma
  • childhood cancer
  • drug induced